BiotechFrance

Announced in January, the deal became effective at the end of April. The platform designed by PathoQuest is intended to perform viral safety testing and genetic characterization for cell and gene therapies, as well as vaccines. With this French acqui

HEADLINE / FRANCE(Paris/Biotech/NGS Diagnostics) - Pathoquest joins the American group Charles River Laboratories, which is exercising its option to acquire the remaining 79% of the share capital for about $60M, after having taken a 21% stake in 2018